ISEC Healthcare Ltd (40T) said shareholders passed all resolutions at its annual general meeting held on Apr, 29 2026.

All items were decided by poll, with each resolution receiving at least 99.9% approval. Key approvals were:

• The adoption of the directors’ statement, audited financial statements and auditor’s report for the year ended Dec, 31 2025.

• A final tax-exempt dividend of 0.58 Singapore cents per ordinary share for FY2025.

• The re-election of Mr Chen Bang and Mr Li Li as directors.

• Directors’ fees of 0.12 million Singapore dollars for FY2026, payable quarterly in arrears.

• The re-appointment of Forvis Mazars LLP as independent auditors, with authority for directors to fix their remuneration.

• General mandates allowing the board to issue new shares, grant options under the ISEC Healthcare Share Option Scheme, grant awards under the ISEC Healthcare Performance Share Plan and to buy back up to 10% of issued shares.

During a shareholder question-and-answer session, management said it has earmarked about 60 million Malaysian ringgit for capital expenditure this year, mainly for a new Kuala Lumpur medical centre, and plans to fund roughly half of future projects with borrowings and the balance with internal cash. Management also expects profit margins to improve as newly opened centres mature.